Ventyx Biosciences Inc. Gains 68.56%
Wed, Feb 21, 2024 at 07:18 PM
Ventyx Biosciences Inc. (VTYX:NASDAQ) shot up at $5.04, a gain of 68.6%. On Wed, Feb 21, 2024, VTYX:NASDAQ hit a New 2-Week High of $5.04. The stock appeared on our News Catalysts scanner on Wed, Feb 21, 2024 at 02:53 PM in the 'BIOTECH' category. From Wed, Feb 07, 2024, the stock recorded 66.67% Up Days and 50.00% Green Days
The stock spiked on Wed, Feb 21, 2024 at $7.5 with a volume of 87M+.
About Ventyx Biosciences Inc. (VTYX:NASDAQ)
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 172.73%
- Greenbrook TMS Inc. (GBNH:NASDAQ), 94.26%
- Emergent BioSolutions Inc. (EBS:NYSE), 78.29%
- Sizzle Acquisition Corp. (SZZL:NASDAQ), 78.11%
- Motus GI Holdings, Inc. (MOTS:NASDAQ), 68.63%
- Ventyx Biosciences Inc. (VTYX:NASDAQ), 68.56%
- Energy Focus, Inc. (EFOI:NASDAQ), 65.94%
- Origin Agritech Limited (SEED:NASDAQ), 62.93%
- LIZHI INC. (SOGP:NASDAQ), 56.74%
- Quantum FinTech Acquisition Corporation (QFTA:NYSEMKT), 51.33%